Terumo BCT - Strategic SWOT Analysis Review

• Publication date: August 2012
• Report size: 25 pages

Terumo BCT - Strategic SWOT Analysis Review Summary Terumo BCT is a privately held US-based pharmaceutical company. It develops products related to the fields of blood banking, therapeutic apheresis and transfusion medicine industries. The company concentrates on blood bank technologies, pathogen reduction technologies, automated blood collection systems, whole blood processing and value-added blood and cell-based therapeutic...

Terumo BCT - Strategic SWOT Analysis Review

Summary

Terumo BCT is a privately held US-based pharmaceutical company. It develops products related to the fields of blood banking, therapeutic apheresis and transfusion medicine industries. The company concentrates on blood bank technologies, pathogen reduction technologies, automated blood collection systems, whole blood processing and value-added blood and cell-based therapeutic products. Terumo BCT has operations across 30 countries and sells its products worldwide through its distribution network. Key business strategy includes increased focus on innovations that are thoughtfully designed, based on extensive consumer insight, to meet the real needs of clinicians and professionals. Terumo BCT is headquartered in Colorado, the US.



In October 2011, the company changed its name from CaridianBCT, Inc. to Terumo BCT after uniting with Terumo Corporation. On April 14, 2011 Terumo Corporation completed acquisition of CaridianBCT and is a wholly-owned subsidiary of the same.



On April 2, 2012, CaridianBCT and Terumo Transfusion have beome Terumo BCT.

Terumo BCT Key Recent Developments

Apr 02, 2012: CaridianBCT And Terumo Transfusion Become Terumo BCT

GlobalData’s Terumo BCT - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Note: Some sections may be missing if data is unavailable for the company.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Blood Supply, Tissue Banking And Transplantation Industry in Canada

Table of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Section 1 - About the Company 4
Terumo BCT - Key Facts 4
Terumo BCT - Key Employees 5
Terumo BCT - Key Employee Biographies 6
Terumo BCT - Major Products and Services 7
Terumo BCT - History 8
Terumo BCT - Company Statement 10
Terumo BCT - Locations And Subsidiaries 11
Head Office 11
Other Locations & Subsidiaries 11
Section 2 – Company Analysis 13
Terumo BCT - Business Description 13
Terumo BCT - Corporate Strategy 14
Terumo BCT - SWOT Analysis 15
SWOT Analysis - Overview 15
Terumo BCT - Strengths 15
Strength - Geographical Diversity 15
Strength - Perpetual Innovation 15
Strength - Wide Product Portfolio 15
Terumo BCT - Weaknesses 15
Weakness - Product Recalls 15
Terumo BCT - Opportunities 16
Opportunity - Acquisition by Terumo Corporation 16
Opportunity - Strategic Alliances and Agreements 16
Opportunity - Market Growth in Emerging Economies 16
Terumo BCT - Threats 16
Threat - Competitive Landscape 16
Threat - Stringent Government Regulations 16
Threat - Risk of Product Obsolescence 17
Terumo BCT - Key Competitors 18
Section 3 – Company’s Lifesciences Financial Deals and Alliances 19
Terumo BCT, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012 19
Terumo BCT, Pharmaceuticals & Healthcare, Deals By Type, 2006 to YTD 2012 20
Terumo BCT, Medical Equipment, Deals By Year, 2006 to YTD 2012 21
Terumo BCT, Medical Equipment, Deals By Type, 2006 to YTD 2012 22
Terumo BCT, Recent Deals Summary 23
Section 4 – Company’s Recent Developments 24
Terumo BCT, Recent Developments 24
Apr 02, 2012: CaridianBCT And Terumo Transfusion Become Terumo BCT 24
Aug 31, 2011: CaridianBCT Launches Mononuclear Cell Collection Protocol For Spectra Optia Apheresis System In Canada 24
Section 5 – Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables

List of Tables
Terumo BCT, Key Facts 4
Terumo BCT, Key Employees 5
Terumo BCT, Key Employee Biographies 6
Terumo BCT, Major Products and Services 7
Terumo BCT, History 8
Terumo BCT, Other Locations 11
Terumo BCT, Key Competitors 18
Terumo BCT, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012 19
Terumo BCT, Pharmaceuticals & Healthcare, Deals By Type, 2006 to YTD 2012 20
Terumo BCT, Medical Equipment, Deals By Year, 2006 to YTD 2012 21
Terumo BCT, Medical Equipment, Deals By Type, 2006 to YTD 2012 22
Terumo BCT, Recent Deals Summary 23

List of Figures

List of Figures
Terumo BCT, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012 19
Terumo BCT, Pharmaceuticals & Healthcare, Deals by Type, 2006 to YTD 2012 20
Terumo BCT, Medical Equipment, Deals By Year, 2006 to YTD 2012 21
Terumo BCT, Medical Equipment, Deals by Type, 2006 to YTD 2012 22

Blood Supply in Canada

Canada Pharmaceutical Exports - Antisera And Other Blood Fractions, Us$mn

• $ 250
• Industry data
• January 2013

Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

• Industries : Blood Supply, Tissue Banking and Transplantation
• Countries : Canada

Canada Pharmaceutical Exports - Other Blood, Toxins, Cultures For Medical Use Not Elsewhere Specified, Us$mn

• $ 250
• Industry data
• January 2013

Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

• Industries : Blood Supply, Tissue Banking and Transplantation
• Countries : Canada

Canada Pharmaceutical Imports - Antisera And Other Blood Fractions, Us$mn

• $ 250
• Industry data
• January 2013

Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

• Industries : Blood Supply, Tissue Banking and Transplantation
• Countries : Canada

Canada Pharmaceutical Imports - Other Blood, Toxins, Cultures For Medical Use Not Elsewhere Specified, Us$mn

• $ 250
• Industry data
• January 2013

Yearly, From 2002 To 2011
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI

• Industries : Blood Supply, Tissue Banking and Transplantation
• Countries : Canada